Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Lyka Trinidad"'
Autor:
Lyka Trinidad, Katerina Leyritana, Rontgene M. Solante, Edsel Maurice T. Salvana, Angelo dela Tonga, Nina Theresa Dungca, Patrick R Ching, Raul V. Destura, Rosario Tactacan-Abrenica, Elizabeth Freda O. Telan, Jodor Lim, Marissa M. Alejandria, Lalaine Arcangel, Kevin Mendoza, Noel S. Palaypayon, Genesis May J. Samonte, Brian Schwem, Geraldine Arevalo, Christine Penalosa-Ramos
Publikováno v:
International Journal of Infectious Diseases, Vol 95, Iss, Pp 125-132 (2020)
Background: The Philippines has the fastest growing HIV epidemic in the Asia-Pacific. This increase was accompanied by a shift in the predominant HIV subtype from B to CRF01_AE. Increasing evidence points to a difference in treatment responses betwee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2bde61b799ed5045067a5b73d36e68c
http://www.sciencedirect.com/science/article/pii/S1201971220300783
http://www.sciencedirect.com/science/article/pii/S1201971220300783
Autor:
Genesis May J. Samonte, Katerina Leyritana, Raul V. Destura, Brian Schwem, Geraldine Arevalo, Christian Francisco, Christine Penalosa-Ramos, Rontgene M. Solante, Kevin Mendoza, Marissa M. Alejandria, Lyka Trinidad, Rosario Tactacan-Abrenica, Edsel Maurice Salvana, Jodor Lim, Elizabeth Freda O. Telan, Patrick R Ching, Nina Theresa Dungca
Publikováno v:
Open Forum Infectious Diseases
Background Doravirine, rilpivirine, and etravirine are newer generation non-nucleoside reverse transcriptase inhibitors (NNRTI) that are intended to be more durable alternatives to efavirenz and nevirapine. We examined transmitted drug resistance (TD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3954cf87bafdc87e8325541c8ea025c
http://europepmc.org/articles/PMC6810627
http://europepmc.org/articles/PMC6810627
Autor:
Lyka Trinidad, Rosario Tactacan-Abrenica, Katerina Leyritana, Edsel Maurice Salvana, Jodor Lim, Genesis May J. Samonte, Brian Schwem, Marissa M. Alejandria, Elizabeth Freda O. Telan, Kevin Mendoza, Geraldine Arevalo
Publikováno v:
Open Forum Infectious Diseases. 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::90fca580bcdeb93354d630cc9dd839d1
https://doi.org/10.1093/ofid/ofw172.1250
https://doi.org/10.1093/ofid/ofw172.1250
Autor:
Verdades P. Linga, Noel S. Palaypayon, Natasha Denise S. Montevirgen, John Edgar S. Tiu, Lyka Trinidad, Jay Arian Caparida, Aiza F. Baldonado, Rolando V. Cruz, Irma L. Asuncion, Jessica Raphaela G. Mirano, Genesis May J. Samonte
Publikováno v:
Annals of Epidemiology. 27:515-516
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4c2923761f7ce02831664bc6f7109e14
https://doi.org/10.1016/j.annepidem.2017.07.059
https://doi.org/10.1016/j.annepidem.2017.07.059
Autor:
Katerina Leyritana, Christine Penalosa, Elizabeth Freda O. Telan, Marissa M. Alejandria, Rosario Tactacan-Abrenica, Genesis May J. Samonte, Geraldine Arevalo, Patrick R Ching, Kevin Mendoza, Lyka Trinidad, Edsel Maurice Salvana, Jodor Lim, Brian Schwem
Publikováno v:
Open Forum Infectious Diseases
Background The WHO-recommended regimen for antiretrovirals (ARVs) is tenofovir (TDF) + lamivudine/emtricitabine (3TC/FTC) + efavirenz (EFV), based on demonstrated superiority of TDF+FTC+EFV over zidovudine (AZT) +FTC+ EFV in clinical trials. However,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::226a0a2d32ba9a7f2d28f5c27d133e02
https://doi.org/10.1093/ofid/ofx163.1081
https://doi.org/10.1093/ofid/ofx163.1081